Most of moderate to severe ulcerative colitis patients in academic clinical practice still do not qualify for randomized controlled trials

Sandra Elmasry, Shabana Pasha, Manreet Kaur, Jonathan A Leighton, Suryakanth R Gurudu, Christina Ha

Open source

DOI
10.1093/crocol/otag092
Published
2026-07
Container
Crohn’s & Colitis 360
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/crocol/otag092,
  title = {Most of moderate to severe ulcerative colitis patients in academic clinical practice still do not qualify for randomized controlled trials},
  author = {Sandra Elmasry and Shabana Pasha and Manreet Kaur and Jonathan A Leighton and Suryakanth R Gurudu and Christina Ha},
  year = {2026},
  journal = {Crohn’s \& Colitis 360},
  doi = {10.1093/crocol/otag092},
  url = {https://doi.org/10.1093/crocol/otag092}
}

RIS

TY  - JOUR
TI  - Most of moderate to severe ulcerative colitis patients in academic clinical practice still do not qualify for randomized controlled trials
AU  - Sandra Elmasry
AU  - Shabana Pasha
AU  - Manreet Kaur
AU  - Jonathan A Leighton
AU  - Suryakanth R Gurudu
AU  - Christina Ha
PY  - 2026
JO  - Crohn’s & Colitis 360
DO  - 10.1093/crocol/otag092
UR  - https://doi.org/10.1093/crocol/otag092
ER  - 

APA

Elmasry, S., Pasha, S., Kaur, M., Leighton, J. A., Gurudu, S. R., & Ha, C. (2026). Most of moderate to severe ulcerative colitis patients in academic clinical practice still do not qualify for randomized controlled trials. Crohn’s & Colitis 360. https://doi.org/10.1093/crocol/otag092

Source records